NasdaqGM - Nasdaq Real Time Price • USD
Cerus Corporation (CERS)
As of 1:06 PM EDT. Market Open.
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 6 | 5 |
Avg. Estimate | -0.05 | -0.03 | -0.1 | -0.06 |
Low Estimate | -0.07 | -0.04 | -0.13 | -0.09 |
High Estimate | -0.04 | -0.02 | -0.08 | -0.04 |
Year Ago EPS | -0.09 | -0.07 | -0.21 | -0.1 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 6 | 6 |
Avg. Estimate | 41.14M | 47.23M | 190.89M | 213.54M |
Low Estimate | 36.4M | 42.5M | 173.3M | 195.2M |
High Estimate | 44.8M | 50.6M | 200M | 236.5M |
Year Ago Sales | 30.97M | 38.85M | 156.37M | 190.89M |
Sales Growth (year/est) | 32.80% | 21.60% | 22.10% | 11.90% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.07 | -0.06 | -0.05 | -0.02 |
EPS Actual | -0.09 | -0.07 | -0.04 | -0.01 |
Difference | -0.02 | -0.01 | 0.01 | 0.01 |
Surprise % | -28.60% | -16.70% | 20.00% | 50.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.05 | -0.03 | -0.1 | -0.06 |
7 Days Ago | -0.05 | -0.03 | -0.1 | -0.06 |
30 Days Ago | -0.05 | -0.03 | -0.1 | -0.06 |
60 Days Ago | -0.05 | -0.03 | -0.11 | -0.06 |
90 Days Ago | -0.05 | -0.03 | -0.11 | -0.06 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | CERS | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 44.40% | -- | -- | 0.30% |
Next Qtr. | 57.10% | -- | -- | 9.80% |
Current Year | 52.40% | -- | -- | 4.50% |
Next Year | 40.00% | -- | -- | 13.40% |
Next 5 Years (per annum) | -- | -- | -- | 11.06% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Initiated | Craig-Hallum: Buy | 4/12/2024 |
Reiterates | Stephens & Co.: Equal-Weight to Equal-Weight | 3/7/2024 |
Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/6/2024 |
Downgrade | BTIG: Buy to Neutral | 1/20/2023 |
Maintains | Stifel: Buy | 5/27/2020 |
Maintains | Stephens & Co.: Overweight | 4/16/2020 |
Related Tickers
RCEL AVITA Medical, Inc.
8.73
-2.78%
DCTH Delcath Systems, Inc.
5.36
-4.21%
ICAD iCAD, Inc.
1.5402
-1.27%
FNA Paragon 28, Inc.
9.71
-3.38%
AXNX Axonics, Inc.
66.70
+0.35%
OM Outset Medical, Inc.
2.5400
+3.25%
AXGN AxoGen, Inc.
6.84
-1.87%
PACB Pacific Biosciences of California, Inc.
1.3650
-7.14%
AORT Artivion, Inc.
20.97
+0.91%
QTRX Quanterix Corporation
15.83
-1.68%